Faslodex
Links shared publicly online about this topic
NICE blames Faslodex rejection on uncertainties in AZ data | InPharm
inpharm.com — “NICE has not recommended a high-dose form of AstraZeneca’s breast cancer drug Faslodex because of uncertainties over its cost-effectiveness” View full resource at inpharm.com
Most Recently Shared on August 23, 2011 at 11:35 am By:
Pharmafocus Pharma and Health News
#NICE blames Faslodex rejection on uncertainties in AZ data http://ow.ly/6aeSq #pharma
Faslodex And Shaking In Hands (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “My wife is taking faslodex 500mg 2 shots in rear This is her second time and she started severe shaking in her hands Has anyone else had this and does a lower dose help stop this and or does this go away ... Learn about and discuss Faslodex and shaking in hands at The People's Medicine Community. (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on July 16, 2011 at 4:35 pm By:
" My wife is taking faslodex 500mg, 2 shots in rear. This is her second time and she started severe shaking http://PD0.US/F220124
NICE won’t back Faslodex in breast cancer | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on November 10, 2011 at 9:48 am By:
Pharmafocus Pharma and Health News
NICE won’t back Faslodex in breast cancer - says current, cheaper treatments just as good - http://t.co/MhlmSADb
FDA Approves New Dosing for Faslodex (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
drugs.com — “Faslodex (fulvestrant) is used to treat metastatic breast cancer. Includes Faslodex side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 12:58 am By:
FDA Approves New Dosing for Faslodex in Treatment of Metastatic Breast Cancer - http://bit.ly/8ZB720
AstraZeneca's Faslodex Drug Not Good Use Of Resources - NICE | FoxBusiness.com
foxbusiness.com — “LONDON -(Dow Jones)- AstraZeneca PLC's (AZN) breast cancer drug Faslodex doesn't represent value for money and consequently shouldn't be made available on the U.K.'s publicly funded National Health Service, according to the country's medical cost-effectiveness body, the National Institute for Health and Clinical Excellence.” View full resource at foxbusiness.com
Most Recently Shared on August 23, 2011 at 12:26 pm By:
Another cancer-drug rejection for NICE: Watchdog says AstraZeneca's Faslodex doesn't beat current therapy. http://t.co/hwLRiGv $AZN
New Drugs, New Combinations Fight Breast Cancer - Drugs.com MedNews
drugs.com — “New therapies and new spins on existing treatments are offering hope for patients with breast cancer, especially those with metastatic disease, according to res” View full resource at drugs.com
Most Recently Shared on December 13, 2009 at 9:35 pm By:
New Drugs, New Combinations Fight Breast Cancer - http://bit.ly/7q3ZVD
New Drugs, New Combinations Fight Breast Cancer:
health.msn.com — “New Drugs, New Combinations Fight Breast Cancer:” View full resource at health.msn.com
Most Recently Shared on December 11, 2009 at 7:29 pm By:
New Drugs, New Combinations Fight Breast Cancer: http://bit.ly/7EgIPu
Breast Cancer Drugs May Fight Cervical Cancer, Too
health.msn.com — “Breast Cancer Drugs May Fight Cervical Cancer, Too” View full resource at health.msn.com
Most Recently Shared on November 9, 2009 at 10:49 pm By:
Breast Cancer Drugs May Fight Cervical Cancer, Too http://bit.ly/4B36Ui
Lombardi Researchers Find Investigational Agent Reduces Tumor Resistance To Breast Cancer Therapy
medicalnewstoday.com — “Researchers at georgetown lombardi comprehensive cancer center have found a way to cleverly override signals that tell breast cancer cells to keep surviving in the face of anticancer treatment. t” View full resource at medicalnewstoday.com
Most Recently Shared on January 7, 2010 at 11:12 am By:
Lombardi Researchers Find Investigational Agent Reduces Tumor Resistance To Breast Cancer Therapy http://mnt.to/3vZm
Data Suggests Improved Disease Control With FASLODEXTM 500mg Compared With Anastrozole For Women With Hormone Receptor-positive Breast Cancer
medicalnewstoday.com — “New data presented at the CTRC-AACR 33rd Annual San Antonio Breast Cancer Symposium, USA, suggest fulvestrant 500mg offers improved disease control compared with the aromatase inhibitor, anastrozo” View full resource at medicalnewstoday.com
Most Recently Shared on December 10, 2010 at 9:05 pm By:
Data Suggests Improved Disease Control With FASLODEXTM 500mg Compared With Anastrozole For Women With Hormone Receptor... http://mnt.to/3NSq
Breast Cancer Drugs May Fight Cervical Cancer, Too - myOptumHealth
myoptumhealth.com — “Read the news article Breast Cancer Drugs May Fight Cervical Cancer, Too at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on November 10, 2009 at 2:17 am By:
Breast Cancer Drugs May Fight Cervical Cancer, Too: Study in mice reports success with drugs that inhibit estrogen http://bit.ly/4vKGUb
Medical News: SABCS: Higher Dose of Fulvestrant Slows Breast Cancer - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- Women with metastatic breast cancer had a modest but statistically significant improvement in time to progression when treated with 500 mg of fulvestrant (Faslodex) -- double the usual” View full resource at medpagetoday.com
Most Recently Shared on December 14, 2009 at 8:07 pm By:
SABCS: Higher Dose of Fulvestrant Slows Breast Cancer (CME/CE) SAN ANTONIO (MedPage Today) -- Women with metastatic b.. http://bit.ly/6aImhF
AstraZeneca News
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on December 11, 2009 at 12:38 am By:
eyeonfda Health Lawyer and Pharma
New AZ Phase3 data from CONFIRM study for FASLODEX® in breast cancer - http://ow.ly/KN75
Dr. Goldstein on Fulvestrant in Metastatic Breast Cancer
onclive.com — “Dr. Lori Goldstein from Fox Chase Cancer Center on Fulvestrant in Metastatic Breast Cancer” View full resource at onclive.com
Most Recently Shared on October 26, 2011 at 10:30 pm By:
Dr. Lori Goldstein from @FoxChaseCancer on Fulvestrant in Metastatic Breast Cancer http://t.co/7dmY7xHz #OncLiveTV
NICE guidance by date
guidance.nice.org.uk — “NICE guidance by date” View full resource at guidance.nice.org.uk
Most Recently Shared on April 27, 2011 at 8:36 am By:
NICE recommends golimumab (Simponi) for psoriatic arthritis and romiplostim (Nplate) for TTP: http://guidance.nice.org.uk/Date
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
-
Medicine Community
Highlights from The People's Medicine Community. Share your drug related questions and stories anonymously in our free community. No registration required.
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
Advertisement
